Padnarsertib, CAS 1643913-93-2

Product Description: Padnarsertib (KPT-9274) is an orally bioavailable, dual PAK4/Nicotinamide phosphoribosyltransferase (Nampt) inhibitor, with IC50s of [1][2][3].

Applications: Cancer-Kinase/protease

Formula: C35H29F3N4O3

References: [1]WO2015003166A1/[2]Abu Aboud O, et al. Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer Growth. Mol Cancer Ther. 2016 Sep;15(9):2119-29./[3]Abu Aboud O, et al. Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer Growth.Mol Cancer Ther. 2016 Sep;15(9):2119-29.

CAS Number: 1643913-93-2

Molecular Weight: 610.63

Compound Purity: 99.86

Research Area: Cancer

Solubility: DMSO : 100 mg/mL (ultrasonic)

Target: NAMPT;PAK

• SKU: MEXHY-12793-10.1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-12793-10.1
• Package Unit: 10 mM/1 ml
• Quantity Unit: STK